Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
Stefan Harsanyi, Zuzana Nováková, Katarína Bevízová, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13206-13206
Open Access | Times Cited: 18

Showing 18 citing articles:

Non-invasive diagnosis for urothelial carcinoma using a dual-target DNA methylation biomarker panel
Jingyao Hou, Yaqian Niu, Jiamin Yan, et al.
Clinica Chimica Acta (2025), pp. 120164-120164
Open Access | Times Cited: 1
Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review
Diego Parrao, Nemecio Lizana, Catalina Saavedra, et al.
Current Oncology (2024) Vol. 31, Iss. 4, pp. 2201-2220
Open Access | Times Cited: 3
The upregulation and transcriptional regulatory mechanisms of Extra spindle pole bodies like 1 in bladder cancer: An immunohistochemistry and high-throughput screening Evaluation
Wei Zhang, Zi-Qian Liang, Rong‐Quan He, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31192-e31192
Open Access | Times Cited: 3
Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis
Che‐Yuan Hu, Hung‐Tsung Wu, Yan‐Shen Shan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6021-6021
Open Access | Times Cited: 8
Network Pharmacology Combined with Bioinformatics Analysis to Texplore the Potential Mechanism of Phellodendri Chinensis Cortex Against Bladder Cancer
Lili Hu, Na Wu, Jue Wang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3317-3331
Closed Access | Times Cited: 2
Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA
Dongin Lee, Wookjae Lee, Hwang‐Phill Kim, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2868-2868
Open Access | Times Cited: 6
Fourier transform IR imaging of primary tumors predicts lymph node metastasis of bladder carcinoma
Monika Kujdowicz, David Pérez-Guaita, Piotr Chłosta, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 8, pp. 166840-166840
Open Access | Times Cited: 5
Molecular Biomarkers of Bladder Cancer: A Mini-Review
Zuzana Nováková, Marcela Kuniaková, Stanislav Žiaran, et al.
Physiological Research (2023) Vol. 72, Iss. S3, pp. S247-S256
Open Access | Times Cited: 5
Analysis of urine cell-free DNA in bladder cancer diagnosis by emerging bioactive technologies and materials
Feifei Huang, Xiao-Fei Di, Mo-Han Bai
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 1
Unveiling the Dichotomy of Urinary Proteins: Diagnostic Insights into Breast and Prostate Cancer and Their Roles
Feng Yan, Qingji Huo, Bai‐Yan Li, et al.
Proteomes (2023) Vol. 12, Iss. 1, pp. 1-1
Open Access | Times Cited: 3
Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis
Xuan Meng, Runfu Cao, Xiaoqiang Liu, et al.
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 2
Advances in Molecular and Translational Medicine
Mariarosaria Boccellino
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7726-7726
Open Access | Times Cited: 2
Telomerase Reverse Transcriptase-Promoter Mutation in Young Patients with Bladder Tumors
Sonia Pérez González, Victoria Heredia-Soto, M. Girón de Francisco, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2845-2855
Open Access
Metastatic Tropism in Urothelial Carcinoma With Variant Histology: A Comprehensive NCDB Analysis
Arthur Drouaud, Vincent Xu, Alejandro Velasquez, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 5, pp. 102179-102179
Closed Access
Chitosan Nanoparticles: Drug Delivery Carriers in Cancer Therapy
K.M. Freny Joy, D. Sathya Seeli, M. Prabaharan
Advances in polymer science (2024)
Closed Access
Biomarkers for predicting bladder cancer therapy response
Ioana Maria Mihai, Gang Wang
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 533-547
Closed Access
SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer
Xiaojing Wang, Peipei Zhang, Jiaqi Yan, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access
Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer—From Early Detection to Prognosis
Natalia Jaszek, Alicja Bogdanowicz, Jan Siwiec, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7159-7159
Open Access
Page 1

Scroll to top